Affinage

BBS9

Protein PTHB1 · UniProt Q3SYG4

Length
887 aa
Mass
99.3 kDa
Annotated
2026-06-09
18 papers in source corpus 5 papers cited in narrative 5 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

BBS9 is required for primary cilium biogenesis across multiple cell types, with its loss abolishing or reducing ciliation in zebrafish Kupffer's vesicle, mouse IMCD3 cells, and patient-derived suture mesenchymal cells (PMID:22479622, PMID:29674126). Structurally, BBS9 is built from four domains, including an N-terminal seven-bladed β-propeller that mediates protein-protein interactions and a C-terminal half that dimerizes in solution, an interface implicated in assembly of the larger ciliary machinery (PMID:26085087). Disease-associated lesions act through two mechanisms: missense mutations such as G141R misfold the β-propeller, and a wild-type but not a missense-mutant BBS9 mRNA rescues the zebrafish ciliary phenotype, directly tying these mutations to loss of ciliary function (PMID:26085087, PMID:22479622). Beyond its requirement for ciliogenesis, BBS9 supports osteogenic differentiation of cranial suture mesenchymal cells, linking ciliary defects to craniosynostosis (PMID:29674126). The molecular partners of BBS9 within the ciliary trafficking machinery are not characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2012 High

    Established that BBS9 is functionally required for cilia, answering whether the gene contributes to ciliogenesis rather than merely being a ciliary marker.

    Evidence Morpholino knockdown in zebrafish and siRNA knockdown in mouse IMCD3 cells with wild-type versus mutant human mRNA rescue

    PMID:22479622

    Open questions at the time
    • Did not define the molecular mechanism by which BBS9 supports cilia assembly
    • No physical partners or complex membership demonstrated
  2. 2015 High

    Resolved the domain architecture of BBS9, showing an N-terminal seven-bladed β-propeller for protein interactions and a C-terminal dimerization interface, and explained how a disease mutation disrupts folding.

    Evidence 1.8 Å X-ray crystallography of the N-terminal domain, solution dimerization studies, and structural analysis of the G141R mutation

    PMID:26085087

    Open questions at the time
    • Only the N-terminal domain was crystallized; full-length structure unresolved
    • Direct interaction partners of the β-propeller not identified
    • Dimerization role in assembly inferred, not shown in an intact complex
  3. 2018 Medium

    Extended BBS9 function to a tissue-specific developmental program, linking its requirement for cilia to osteogenic differentiation in cranial suture cells.

    Evidence siRNA knockdown in patient-derived suture mesenchymal cells with cilia staining and in vitro osteogenic differentiation assay

    PMID:29674126

    Open questions at the time
    • Single lab, single study
    • Mechanistic link between ciliary loss and impaired osteogenesis not established
  4. 2021 Low

    Characterized a splice-site variant producing a truncated BBS9 lacking C-terminal domain sequence, connecting genotype to predicted protein disruption.

    Evidence Patient mRNA exon-skipping analysis and 3D structural modelling

    PMID:33771153

    Open questions at the time
    • Effect on protein function inferred from modelling only, not measured
    • No functional assay of the truncated product
  5. 2024 Medium

    Demonstrated that a missense variant additionally acts through aberrant splicing, refining how specific alleles produce milder, hypomorphic outcomes.

    Evidence In vitro minigene splice assay

    PMID:38534779

    Open questions at the time
    • Splicing outcome shown in minigene, not patient tissue
    • Functional consequence on cilia not assayed

Open questions

Synthesis pass · forward-looking unresolved questions
  • The direct physical partners of BBS9 and the molecular steps by which it mediates ciliary trafficking remain undefined in the available corpus.
  • No interaction partners experimentally identified in the timeline
  • No reconstitution of BBS9 within an intact ciliary complex
  • Mechanism connecting ciliary function to osteogenesis unresolved

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Localization
GO:0005929 cilium 2
Pathway
R-HSA-1266738 Developmental Biology 1 R-HSA-1852241 Organelle biogenesis and maintenance 1

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2015 Crystal structure of the BBS9 N-terminal domain was solved at 1.8 Å resolution, revealing a seven-bladed β-propeller. The protein is composed of four structured domains total. Structure-based homology search suggests the β-propeller functions in protein-protein interactions. The disease-causing G141R mutation in BBS9 likely causes misfolding of the β-propeller. The C-terminal half of BBS9 dimerizes in solution, whereas the N-terminal domain only dimerizes in the crystal lattice; this C-terminal dimerization interface may be important for BBSome assembly. X-ray crystallography (1.8 Å), size-exclusion chromatography/solution studies, structure-based homology search, structural analysis of disease mutation The Journal of biological chemistry High 26085087
2012 Morpholino knockdown of bbs9 in zebrafish caused developmental abnormalities including retinal defects, brain abnormalities (hydrocephaly), and reduced number and length of cilia in Kupffer's vesicle, consistent with ciliopathy phenotypes. Knockdown of Bbs9 in mouse IMCD3 cells resulted in absence of cilia. Wild-type human BBS9 mRNA rescued the zebrafish morphant phenotype, but mRNA carrying a BBS patient missense mutation could not rescue, demonstrating that BBS9 is required for cilia biogenesis and/or function. Antisense morpholino knockdown in zebrafish, siRNA knockdown in mouse IMCD3 cells, mRNA rescue experiments (wild-type vs. mutant), cilia counting/measurement PloS one High 22479622
2018 BBS9 functional knockdown in nonsyndromic craniosynostosis patient suture-derived mesenchymal cells reduced primary cilia formation and impaired osteogenic differentiation potential, indicating BBS9 is required for primary cilia assembly on these cells and for their normal osteogenic capacity. siRNA/functional knockdown in patient-derived suture mesenchymal cells, primary cilia staining, in vitro osteogenic differentiation assay Bone Medium 29674126
2021 A novel homozygous splice-site variant in BBS9 (c.702+1del) causes skipping of exon 7, resulting in a truncating effect with partial deletion of the PHTB1_N domain and total deletion of the PHTB1_C domain, as demonstrated by mRNA expression analysis and 3D structural modelling. mRNA expression analysis (exon skipping), 3D structural modelling BMC medical genomics Low 33771153
2024 A missense variant in BBS9 (c.263C>T; p.Ser88Leu) located at the last base of Exon 3 leads to partial aberrant splicing of Exon 3, as demonstrated by an in vitro minigene splice assay, suggesting a hypomorphic allele consistent with the milder phenotype observed. In vitro minigene splice assay Current issues in molecular biology Medium 38534779

Source papers

Stage 0 corpus · 18 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2018 Cytogenomic identification and long-read single molecule real-time (SMRT) sequencing of a Bardet-Biedl Syndrome 9 (BBS9) deletion. NPJ genomic medicine 99 29367880
2012 Knockdown of Bardet-Biedl syndrome gene BBS9/PTHB1 leads to cilia defects. PloS one 44 22479622
2015 Targeted multi-gene panel testing for the diagnosis of Bardet Biedl syndrome: Identification of nine novel mutations across BBS1, BBS2, BBS4, BBS7, BBS9, BBS10 genes. European journal of medical genetics 39 26518167
2015 Structural Characterization of Bardet-Biedl Syndrome 9 Protein (BBS9). The Journal of biological chemistry 16 26085087
2016 Homozygosity mapping identified a novel protein truncating mutation (p.Ser100Leufs*24) of the BBS9 gene in a consanguineous Pakistani family with Bardet Biedl syndrome. BMC medical genetics 13 26846096
2018 BBS9 gene in nonsyndromic craniosynostosis: Role of the primary cilium in the aberrant ossification of the suture osteogenic niche. Bone 11 29674126
2020 Testis-enriched circular RNA circ-Bbs9 plays an important role in Leydig cell proliferation by regulating a CyclinD2-dependent pathway. Reproduction, fertility, and development 9 31708014
2019 Exome sequence analysis in consanguineous Pakistani families inheriting Bardet-Biedle syndrome determined founder effect of mutation c.299delC (p.Ser100Leufs*24) in BBS9 gene. Molecular genetics & genomic medicine 9 31294530
2023 Significant role of circRNA BBS9 in chronic obstructive pulmonary disease via miRNA-103a-3p/BCL2L13. BMC pulmonary medicine 8 37442983
2024 Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment. Frontiers in immunology 7 39139574
2021 Novel homozygous protein-truncating mutation of BBS9 identified in a Chinese consanguineous family with Bardet-Biedl syndrome. Molecular genetics & genomic medicine 6 34212515
2021 Novel biallelic variant in BBS9 causative of Bardet-Biedl syndrome: expanding the spectrum of disease-causing genetic alterations. BMC medical genomics 5 33771153
2021 A Novel BBS9 Mutation Identified via Whole-Exome Sequencing in a Chinese Family with Bardet-Biedl Syndrome. BioMed research international 5 34692830
2022 Next-generation sequencing identified novel truncating mutations in BBS9 causing Bardet Biedl syndrome in two Iranian consanguineous families. Iranian journal of child neurology 2 35222663
2024 Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9. Current issues in molecular biology 1 38534779
2024 Novel BBS1 deletion and BBS9 nonsense pathogenic variant in Bardet-Biedl syndrome. Ophthalmic genetics 1 39618083
2024 Homozygous Pathogenic Variant in BBS9 Gene: A Detailed Case Study of Bardet-Biedl Syndrome. Cureus 0 39211725
2024 Novel genotyping assay for a 212-kb deletion from the BBS9 gene, and frequency of the allele in pig populations in Vietnam. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 0 39327728

Missed literature

Know a paper Affinage missed for BBS9? Flag it for the maintainers and the community.

No submissions yet.